行业
解决方案
实力
关于
洞察
行业
解决方案
实力
关于
洞察
探索 Sanner 的白皮书和行业报告合集，涵盖医疗保健包装和医疗器械开发领域的研究洞察、最佳实践和技术专业知识。下载与您的产品和市场最相关的资源。
白皮书
This whitepaper analyzes the causes of injection pain, identifies an under-explored area for improvement, and presents a simple mechanical concept that might ameliorate the problem.
As healthcare technologies become increasingly sophisticated and connected, compliance with the IEC 60601 series of standards is not simply a regulatory requirement, it is a fundamental design consideration.
Custom ocular injection devices present unique challenges. This whitepaper highlights key considerations and insights we have gained through years of experience accelerating ophthalmic delivery device programs from concept to market.
For pharmaceutical and medical device companies, sustainability is increasingly becoming a regulatory requirement, a shareholder expectation, and a need in commercial partnerships. As shown in this whitepaper, Sanner's approach combines end-to-end services and clean energy manufacturing infrastructure to help our partners meet emissions targets at scale.
Gene therapy has emerged as a promising frontier in modern medicine, offering potential cures for previously untreatable genetic disorders. In this whitepaper, we'll look at in vivo and ex vivo approaches and dive into the devices, challenges and delivery methods.
Medical packaging requirements are increasing continuously. To satisfy these requirements with ease, walk through an example of a time-tested individual development process in this whitepaper.
出版物专题
Dr. Sammy Hassan delves into the measures required to ensure safe and reliable use of wearable drug delivery pumps, explaining the difficulties and benefits of incorporating such standards into a device.
Kiara Taylor delves into the challenges of changing materials to enhance sustainability after a design has been transferred to manufacturing, considering the reasons that might drive such a change, the issues involved and the benefits that can be gained.
A new reality is forming as we enter 2026 – it will not be “business as usual”. Here, Tom Oakley and Alex Vasiev cover those changes, the incretin juggernaut and the march of technical progress with “minitablet” dispensers, large-volume injectors and dual-chamber devices.
Dr. Ethan Miller examines the manufacturing of cell and gene therapies where shear stress can impact cells and explores strategies to mitigate such damage.
Bradley Sawyer, Elena Guss Tarazona, Matthew Latham, Charlie Bowen, Dr. Jay Sayed, and Harriet Field describe new software co-developed by Sanner and Pfizer to translate syringe test data into injection device performance.
Adam Nightingale explores a multitude of approaches to achieving more efficient and sustainable production of medical devices when partnering with a CDMO, and demonstrates the ways in which these partnerships can offer reduced risk and comply with regulations when streamlining industrialisation.